HIV-1 escape from RNAi antivirals: Yet another houdini action

Molecular Therapy Nucleic Acids

Volumn 1, Issue 6, 2012, Pages

  Berkhout, Ben ^a   Das, Atze T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; SMALL INTERFERING RNA;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; VIRUS REPLICATION;

EID: 85015391748     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2012.22     Document Type: Letter

References (19)

1. Shah, PS, Pham, NP and Schaffer, DV (2012). HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites. Mol Ther 20: 840-848.
2. Lee, SK, Dykxhoorn, DM, Kumar, P, Ranjbar, S, Song, E, Maliszewski, LE et al. (2005). Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106: 818-826. (Pubitemid 41076420)
3. ter Brake, O, Konstantinova, P, Ceylan, M and Berkhout, B (2006). Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 14: 883-892. (Pubitemid 44743127)
4. Das, AT, Brummelkamp, TR, Westerhout, EM, Vink, M, Madiredjo, M, Bernards, R et al. (2004). Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 78: 2601-2605. (Pubitemid 38228957)
5. Boden, D, Pusch, O, Lee, F, Tucker, L and Ramratnam, B (2003). Human immunodeficiency virus type 1 escape from RNA interference. J Virol 77: 11531-11535. (Pubitemid 37271651)
6. Holz, CL, Albina, E, Minet, C, Lancelot, R, Kwiatek, O, Libeau, G et al. (2012). RNA interference against animal viruses: how morbilliviruses generate extended diversity to escape small interfering RNA control. J Virol 86: 786-795.
7. Nevot, M, Martrus, G, Clotet, B and Martínez, MA (2011). RNA interference as a tool for exploring HIV-1 robustness. J Mol Biol 413: 84-96.
8. von Eije, KJ, ter Brake, O and Berkhout, B (2008). Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol 82: 2895-2903. (Pubitemid 351329179)
9. Gitlin, L, Stone, JK and Andino, R (2005). Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79: 1027-1035. (Pubitemid 40053886)
10. ter Brake, O, von Eije, KJ and Berkhout, B (2008). Probing the sequence space available for HIV-1 evolution. AIDS 22: 1875-1877.
11. Berkhout, B and Klaver, B (1995). Revertants and pseudo-revertants of human immunodeficiency virus type 1 viruses mutated in the long terminal repeat promoter region. J Gen Virol 76 (Pt 4): 845-853.
12. Das, AT, Harwig, A, Vrolijk, MM and Berkhout, B (2007). The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription. J Virol 81: 7742-7748. (Pubitemid 47047860)
13. Westerhout, EM, Ooms, M, Vink, M, Das, AT and Berkhout, B (2005). HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33: 796-804. (Pubitemid 40361009)
14. Westerhout, EM and Berkhout, B (2007). A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res 35: 4322-4330. (Pubitemid 47244586)
15. Leonard, JN, Shah, PS, Burnett, JC and Schaffer, DV (2008). HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 4: 484-494.
16. Berkhout, B (2009). A new Houdini act: multiple routes for HIV-1 escape from RNAi-mediated inhibition. Future Microbiol 4: 151-154.
17. Berkhout, B, Verhoef, K, van Wamel, JL and Back, NK (1999). Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J Virol 73: 1138-1145. (Pubitemid 29036765)
18. Low, JT, Knoepfel, SA, Watts, JM, ter Brake, O, Berkhout, B and Weeks, KM (2012). SHAPE-directed discovery of potent shRNA inhibitors of HIV-1. Mol Ther 20: 820-828.
19. ter Brake, O, Legrand, N, von Eije, KJ, Centlivre, M, Spits, H, Weijer, K et al. (2009). Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. Gene Ther 16: 148-153.